Amazon is launching a new GLP-1 program through One Medical and Amazon Pharmacy to streamline access to popular weight-loss ...

Responding to consumer needs and aided by technology, the department’s influence now encompasses the entire store ...

GLP-1 drugs are meant to treat metabolic diseases like diabetes and obesity. But as they become more available, some people might choose to use them even if they're not currently overweight. NPR's ...

Experts describe the development of oral GLP-1 medication as a “pivotal” improvement in the accessibility and adherence to obesity drugs. As of February 2026, only Wegovy and Rybelsus are available in ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

There is no shortage of headlines about GLP-1 medications. Originally developed to manage blood sugar levels, these medications are now widely known for promoting weight loss. Alongside their rapid ...

Roel van den Akker evaluates how blockbuster GLP-1s may shift broader commercialization trends. The GLP-1 market's evolution ...

The ASA guidance suggests that patients on GLP-1 drugs should consult their healthcare providers well in advance of any ...

Hims & Hers Health shares declined on Thursday as investors reacted cautiously to the company’s latest expansion in GLP-1 ...

Amazon (AMZN) launches GLP-1 weight loss program, sending Hims & Hers (HIMS) stock down 6% as competition heats up in the ...

GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...